When was ONI founded?

ONI was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is ONI located?

ONI is headquartered in Oxford, United Kingdom.

Which legal entities is ONI associated with?

ONI is associated with Oxford Nanoimaging Limited and 1 other.

How many employees does ONI have?

As of Sep 30, 2026, the latest employee count at ONI is 208.

Is ONI a funded company?

ONI is a funded company, having raised a total of $113M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 30, 2016.

How much is ONI worth?

The latest valuation of ONI is £***** as of Dec 21, 2021.

When was the latest funding round of ONI?

ONI's latest funding was a $***** Series B round on Dec 21, 2021, with participation from 8 investors.

What is the annual revenue of ONI?

Annual revenue of ONI is between £1M and £10M as on Dec 31, 2024

Where does ONI rank among its competitors?

ONI ranks 3rd amongst 214 active competitors, of which 32 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Medprime Technologies, which secured $1.31M in Sep, 2024.

Who are the top competitors of ONI?

ONI's top competitors include ZEISS, Oxford Instruments and FEI Company. Among them, Medprime Technologies secured the most recent funding round in September, 2024.

ONI - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Biotechnology company specializing in super-resolution microscopy systems. These instruments utilize single molecule localization techniques to visualize biological structures at the nanoscale. The product line includes benchtop microscopes capable of various imaging modalities such as dSTORM, PALM, and DNA-PAINT. These systems support applications in cell biology, microbiology, and nanoparticle characterization. The hardware integrates with cloud-based software platforms designed for data analysis, clustering, and collaborative research. Additionally, the company provides reagents and kits to facilitate sample labeling and preparation for high-precision imaging workflows.

Website: oni.bio
Social
Email ID: *****@oni.bio
Phone Number: +39 **********

Key Metrics

Founded Year

2016

Location

Oxford, United Kingdom

Stage

Series B

Total Funding

$113M in 7 rounds

Latest Funding Round

Series B, Dec 21, 2021, $*****

Post Money Valuation

£***** as on Dec 21, 2021

Investors

Arch Venture Partners & 22 more

Ranked

3^rd among 214 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2024

Employee Count

208 as on Sep 30, 2026

Similar Companies

M Squared & 48 more

View ONI's full profile

ONI is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Oxford Nanoimaging Limited CIN: 10023177 , United Kingdom, Active		£1M - £10M (As on Dec 31, 2024)	97 (As on Dec 31, 2024)
THRIVE OPERATIONS LIMITED CIN: 2698057 , Germany, Active	Mar 16, 1992	-	178 (As on Dec 31, 2024)

ONI has raised a total funding of $113M over 7 rounds. Its first funding round was on Apr 30, 2016. Its latest funding round was a Series B round on Dec 21, 2021 for $*****. 8 investors participated in its latest round. ONI has 20 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of ONI:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 21, 2021	6428054	Series B	7593569	7691003	6075528	6935615
Jun 01, 2021	9562584	Grant (prize money)	1442241	5896830	9663662	Europa
Aug 28, 2020	9055555	Series A	6519624	7508231	1534565	7540423

Access funding benchmarks and valuations. Sign up today!

View details of ONI's funding rounds and investors

The founders of ONI are Jeremy Warren and Achillefs Kapanidis. Paul Scagnetti is the CEO of ONI.

Here are the details of ONI's key team members:

Jeremy Warren: Former Co-Founder of ONI and founder of 1 other company. They are also an angel investor in 1 startup.
Achillefs Kapanidis: Co-Founder of ONI and founder of 1 other company.
Paul Scagnetti: CEO of ONI.
Contact Info: 1 email address

ONI's Board of Directors

ONI's board has 6 active members. Paul Albert Scagnetti is part of team and Keith Lawrence Crandell, Ekaterina Smirnyagina, Alex Parker, Alexander Aravanis and Patrick John Finn are independent board members.

Here is the list of ONI's board of directors:

Name	Type	Representing	Status	Duration
hkrvrcz	Team	-	Current	3y 7m
kopffrf	Team	-	Past	7y 3m
Keith Lawrence Crandell	Independent board member	-	Current	4y 9m
myeksij	Independent board member	-	Current	7y 3m
fjgbdnr	Independent board member	-	Current	3y 8m
jtqexob	Independent board member	-	Current	9y 1m
{ihdunf	Independent board member	-	Current	2y 2m
lxrksap	Independent board member	-	Past	6y 7m
xbyhpnw	Independent board member	-	Past	4y 7m
k{qemgs	Independent board member	-	Past	9y 8m
y{yc{h{	Independent board member	-	Past	7y 1m
cxxykkk	Independent board member	-	Past	2y 5m

View details of ONI's Founder profiles and Board Members

ONI's employee count trend

ONI has 208 employees as of Sep 26. Here is ONI's employee count trend over the years:

Uncover ONI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ONI include ZEISS, Oxford Instruments and FEI Company. Here is the list of Top 10 competitors of ONI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ZEISS 1846, Oberkochen (Germany), Public	Provider of diversified optics for microscopic instruments, medical imaging systems and more	$49.8M	EQT, Bundesministerium fur Wirtschaft und Klimaschutz ... & 5 others	76/100
2nd	Oxford Instruments 1959, High Wycombe (United Kingdom), Public	Manufacturer of scientific technology for atomic and molecular level research	-	Europa	69/100
3rd	ONI 2016, Oxford (United Kingdom), Series B	Biotechnology company specializing in super-resolution microscopy systems	$113M	GT Healthcare Capital Partners, Artis Ventures ... & 21 others	67/100
4th	FEI Company 1971, Hillsboro (United States), Acquired	Electron microscopy solutions for advancing scientific discovery and industrial innovation	$300K	Starboard Capital Partners, Reference Capital Management ... & 2 others	65/100
5th	Medprime Technologies 2014, Thane (India), Seed	Developer of digital microscopes for pathology and telepathology	$1.71M	SINE, RiSo Capital & 25 others	61/100
6th	Park Systems 1997, Suwon-si (South Korea), Public	Manufacturer of atomic force microscopy and metrology instrumentation and solutions	-	JAFCO Asia	60/100
7th	M Squared 2006, Glasgow (United Kingdom), Series B	Developer of light-sheet microscopy systems for multiple business verticals	$30.7M	BGF, Barclays & 9 others	60/100
8th	Leica Microsystems 1914, Wetzlar (Germany), Acquired	Manufacturer of microscopes, microscope software, cameras, parts, and accessories	-	SV Health Investors, Westlake Ventures & 1 others	59/100
9th	Nicoya Life 2012, Kitchener (Canada), Series A	Provider of hyperspectral optical microscopes for surface analysis	$35M	Whitecap Venture Partners, Golden Triangle Angel Network ... & 19 others	59/100
10th	Tomocube 2015, Daejeon (South Korea), Public	Holographic microtomography for cellular microscopy	$2M	SBVA, Company K Partners & 4 others	57/100